We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05230810
Brief Title: Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.

First Submitted : December 27, 2021
First Submitted that Met QC Criteria : January 28, 2022
First Posted : February 9, 2022

Last Update Submitted that Met QC Criteria : December 29, 2022
Last Update Posted : January 3, 2023